Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
AbbVie
ABBV
|
$3.06B |
| 2 |
Pfizer
PFE
|
$1.93B |
| 3 |
Bristol-Myers Squibb
BMY
|
$1.67B |
| 4 |
Morgan Stanley
MS
|
$1.59B |
| 5 |
Constellation Energy
CEG
|
$1.25B |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$2.84B |
| 2 |
Gilead Sciences
GILD
|
$1.81B |
| 3 |
Union Pacific
UNP
|
$1.68B |
| 4 |
Exelon
EXC
|
$1.35B |
| 5 |
Microsoft
MSFT
|
$1.33B |
Sector Composition
| 1 | Technology | 23.02% |
| 2 | Financials | 14.78% |
| 3 | Healthcare | 14.09% |
| 4 | Communication Services | 11.78% |
| 5 | Industrials | 8.36% |
